Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AJ201 Food Effect and PK Study in Healthy Japanese and White Males
NCT07549919Phase 1Recruiting
- Sponsor
- AnnJi Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosolutamide (2 arms), sponsored by AnnJi Pharmaceutical Co., Ltd. Primary endpoints: Plasma Pharmacokinetics of AJ201 at Day 6 and Urine Pharmacokinetics of AJ201 at Day 7. Started Apr 2026; status: recruiting.
02
Drugs
rosolutamide
Beyond the preview
Go deeper on NCT07549919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549919.